布林佐胺联合曲伏前列素治疗原发性开角型青光眼的临床疗效和安全性

布林佐胺联合曲伏前列素治疗原发性开角型青光眼的临床疗效
和安全性
倪莉莎;李俊;叶锌铭;高和香
【期刊名称】《中国生化药物杂志》
【年(卷),期】2017(000)004
【摘要】目的探讨布林佐胺联合曲伏前列素治疗原发性开角型青光眼的临床疗效和安全性.方法选取2015年3月～2016年3月丽水市人民医院收治的112例(140眼)开角型青光眼患者,将其按照随机数字法随机分为A组和B组,每组56例(70眼),A组给予曲伏前列素进行治疗,B组给予曲伏前列素联合布林佐胺进行治疗,观察并比较2组治疗后的临床疗效并评价治疗期间2组的不良反应.结果用药2 w、1个月、3个月、6个月后2组眼压均显著低于用药前,差异有统计学意义(P<0.05),但B组用药2 w、1个月、3个月、6个月后眼压均显著低于A组,差异有统计学
意义(P<0.05).治疗后,2组BUT及ST均较用药前显著降低,差异有统计学意义
(P<0.05),但2组用药后BUT及ST比较差异无统计学意义;2组角膜荧光素染色及
眼表虎红染色评分均较用药前显著升高,差异有统计学意义( P <0.05),但2组用药
后角膜荧光素染色及眼表虎红染色评分比较差异无统计学意义.2组不良反应发生
率比较差异无统计学意义.结论布林佐胺联合曲伏前列素治疗可降低原发性开角型青光眼患者的眼内压,但可降低泪膜稳定性,损伤角膜、结膜,减少泪液分泌,与单用曲伏前列素相当.%Objective To investigate the clinical efficacy and safety of brinzolamide combined with travoprost in the treatment of primary open-angle glaucoma.Methods 112 cases(140 eyes)of open-angle glaucoma patients from March 2015 to March 2016 were selected and randomly
divided into the group A and the group B 56 cases(70 eyes)in each group.The group A was treated with travoprost therapy,while the group B was given travoprost combined with brinzolamide treatment,the adverse reactions and clinical curative effects in the two groups were observed and compared during treatment.Results After two weeks,one months,three months and six months in the two groups intraocular pressure were significantly lower than those before treatment,the difference was statistically significant(P<0.05),but in two weeks,one months,three months and six months in the group B the intraocular pressure was significantly lower than that in the group A,the difference was statistically
significant(P<0.05).After treatment,two groups of BUT and ST were decreased significantly lower than before treatment,the difference was statistically significant(P<0.05),but there was no significant difference between BUT and ST after treatment,two groups of corneal fluorescein staining and ocular; Bengal staining scores were all significantly higher than before treatment,the difference was statistically
significant(P<0.05),however,there was no significant difference in corneal fluorescein staining and ocular surface of rose bengal staining between the two groups.There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion Brinzolamide combined with travoprost can reduce the intraocular pressure of patients with primary open-angle glaucoma,but can reduce tear film stability,damage the cornea,conjunctiva,reduce tear secretion,there is some damage to the conjunctiva,cornea,similar with travoprost.
【总页数】3页(P229-231)
【作者】倪莉莎;李俊;叶锌铭;高和香
【作者单位】丽水市人民医院眼科,浙江丽水 323000;丽水市人民医院眼科,浙江丽水 323000;丽水市人民医院眼科,浙江丽水 323000;丽水市人民医院眼科,浙江丽水 323000
【正文语种】中文
【中图分类】R775.2
【相关文献】
1.噻吗洛尔与布林佐胺联合曲伏前列素治疗原发性开角型青光眼的疗效比较 [J], 赵树伦
2.噻吗洛尔和布林佐胺联合曲伏前列素治疗原发性开角型青光眼与高眼压患者的临床研究 [J], 王建萍;赵燕麟;马勇;朱涛;程燕;车选义;赵桂娥;王柯
3.曲伏前列素联合布林佐胺治疗原发性开角型青光眼的临床疗效及安全性 [J], 覃水喷; 李成智; 韦茹倩
4.布林佐胺联合曲伏前列素治疗原发性开角型青光眼的临床疗效和安全性 [J], 陈佩媛
5.布林佐胺联合曲伏前列素治疗原发性开角型青光眼的临床疗效和安全性 [J], 陈佩媛
因版权原因，仅展示原文概要，查看原文内容请购买。